Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB-119 in Untreated Type 2 Diabetes Mellitus (Phase II)
CTR20180514Phase 2Completed
- Sponsor
- PegBio
- Start
- Apr 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of visepegenatide in type 2 diabetes mellitus (T2DM), sponsored by PegBio. Started Apr 2018; status: completed.
02
Drugs
visepegenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20180514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180514.